Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Keratin 18 pseudogene 23 (KRT18P23) is a processed pseudogene of the human keratin 18 gene. While the functional KRT18 gene encodes an intermediate filament protein widely expressed in simple epithelial cells and has roles in cellular structure and disease processes, the KRT18P23 pseudogene does not encode a functional protein and has no demonstrated biological or therapeutic significance[5][7][6]. The human genome contains a large number of keratin pseudogenes, including more than 70 pseudogenes for keratin 18, none of which contain an intact reading frame or known function[5][7]. KRT18P23 is therefore not considered a biological or therapeutic target. Note: This is distinct from the functional Keratin 18 (KRT18), which is a cytoskeletal protein involved in epithelial cell integrity, apoptosis, and carcinogenesis and is used as a clinical biomarker, but KRT18P23 is not the same entity[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Keratin 18 pseudogene 23 (KRT18P23).